Table 3 Clinical outcomes of bleeding control
Variables | Conventional therapy (n = 112) | UI-EWD therapy (n = 55) | P-value |
|---|---|---|---|
Success of immediate hemostasis, n (%) | 112 (100%) | 55 (100%) | |
Cumulative re-bleeding, n (%) | |||
At 7 days | 14 (12.5) | 3 (5.5) | 0.157 |
At 14 days | 16 (14.3) | 3 (5.5) | 0.091 |
At 28 days | 19 (17.0) | 3 (5.5) | 0.039 |
Time to re-bleeding (days)§ | 5 (1–25) | 4 (1–5) | |
Adverse event, n (%) | |||
Colonic obstruction | 0 (0.0) | 0 (0.0) | - |
Perforation | 1 (0.9) | 0 (0.0) | - |
Infection | 1 (0.9) | 0 (0.0) | 0.448+ |
Embolization | 0 (0.0) | 0 (0.0) | - |